COMMUNIQUÉS West-GlobeNewswire

BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance
04/03/2026
MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, [...]
Larimar Therapeutics to Participate in Upcoming Investor Conferences in March
04/03/2026
BALA CYNWYD, Pa., March 04, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today [...]
Eledon Pharmaceuticals to Participate in Leerink Partners 2026 Global Healthcare Conference
04/03/2026
IRVINE, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, and Steven Perrin, Ph.D., President [...]
Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment
04/03/2026
Indomo Developing Fast-Acting, At-Home Treatment for Inflammatory Acne Lesions to be Administered with the ClearPen ™ , its Proprietary Intradermal Self-Injection Device Lifecore to Manufacture Drug Batches in [...]
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04/03/2026
NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on March 1, 2026, the Company [...]
LB Pharmaceuticals to Participate in Upcoming March Investor Events
04/03/2026
NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar [...]
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
04/03/2026
LEXINGTON, Mass., March 04, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel [...]
Aquestive Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
04/03/2026
Reaffirms guidance to resubmit Anaphylm™ (dibutepinephrine) sublingual film NDA in Q3 2026; Type A meeting with FDA expected to occur within 30 days On track to submit regulatory applications for Anaphylm in Canada and [...]
Galapagos Receives Transparency Notifications from Bank of America
04/03/2026
Mechelen, Belgium ; March 4, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America. Pursuant to Belgian transparency legislation 1 [...]
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/03/2026
BOSTON, March 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced that [...]
MAIA Biotechnology Announces Closing of $30 Million Underwritten Public Offering of Common Stock
04/03/2026
Financing included participation by healthcare-dedicated investors alongside existing shareholders CHICAGO, IL, March 04, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company [...]
Bioxytran Announces Positive Dose Optimization Results and Advances Toward Phase 3 Registrational Trial for ProLectin-M
04/03/2026
Company Initiates Regulatory Discussions with CDSCO; Plans 408-Patient Pivotal Study Targeting Standard-Risk Several Viral Infected Outpatients BOSTON, March 04, 2026 (GLOBE NEWSWIRE) -- Bioxytran, Inc. (OTCQB: BIXT) [...]
Coloplast appoints Gavin Wood as new CEO
04/03/2026
Announcement no. 3/2026 Inside information Coloplast appoints Gavin Wood as new CEO The Coloplast Board of Directors is pleased to announce the appointment of Gavin Wood as the new President and Chief Executive Officer [...]
Predictors of Success for 60-Day Peripheral Nerve Stimulation (PNS) Used for Treatment of Chronic Shoulder Pain: A Multi-Center Retrospective Chart Review
04/03/2026
- Bimodal stimulation produced significantly higher shoulder pain relief compared to other stimulation paradigms - CLEVELAND, March 04, 2026 (GLOBE NEWSWIRE) -- Shoulder pain is one of the most common locations of [...]
Los Angeles Orthodontist McComb Orthodontics Reaches 5,000 Invisalign Cases, Earns Sapphire Status
04/03/2026
LOS ANGELES, March 04, 2026 (GLOBE NEWSWIRE) -- Invisalign provider McComb Orthodontics , a specialty orthodontic practice with clinics in West Hollywood and Culver City, has reached Sapphire status, Invisalign’s [...]
Compass Health Expands YGo Youth Mobile Crisis Services Across Northwest Washington
04/03/2026
YGo teams in Snohomish, Skagit, and Whatcom counties provide immediate, short-term behavioral health support for youth and families EVERETT, Wash., March 04, 2026 (GLOBE NEWSWIRE) -- Compass Health has expanded its YGo [...]
TLI Selects Higher Logic to Power Community Collaboration on the Autism Knowledge Gateway
04/03/2026
MCLEAN, Va., March 04, 2026 (GLOBE NEWSWIRE) -- The Thought Leadership & Innovation Foundation (TLI) is proud to announce its adoption of the Higher Logic platform to power community engagement and clinical [...]
Communiqué de presse : Dépôt d’un amendement au Document d’Enregistrement Universel 2025, contenant le Rapport Financier Annuel
04/03/2026
Dépôt d’un amendement au Document d’Enregistrement Universel 2025, contenant le Rapport Financier Annuel Paris, le 4 mars 2026 . Sanofi annonce avoir déposé ce jour un amendement à son Document d’Enregistrement [...]
Press Release: Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report
04/03/2026
Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report Paris, March 4, 2026 . Sanofi announces today the filing of an amendment to its “Document d’ [...]

Pages